News & Media
Learn more about the latest happenings at Otsuka. Select to see US news or read our press releases. You can also stay up to date with our global news in the link below.
Media Contact:
Senior Director, External Communications,
Otsuka America Pharmaceutical, Inc
$80m raised will further the development of psilocybin therapyLondon, UK – 27 April 2020 COMPASS Pathways, a mental health care company, announced today that it has completed a successful $80m Series B investment round. This funding will expand upon COMPASS’s lead programme in psilocybin therapy for treatment-resistant depression, supporting research into additional indications for
Grants Distributed to Four Non-Profit Organizations Serving Patients, Healthcare Workers and Their Families Dealing with the Impact of COVID-19 April 23, 2020 – Princeton, NJ – As part of its continuing commitment to helping those in need with mental health and kidney diseases, the Sozosei Foundation, a U.S.-based, private charitable foundation committed to the health and well-being of our
PRINCETON, N.J. (April 10, 2020) – Otsuka announces today the extension of its patient support programs, Otsuka Patient Support and Otsuka Patient Assistance Foundation, to provide “no-cost” access to its branded portfolio of prescription medicines for patients in the U.S. who have lost a job or health insurance coverage due to the COVID-19 (coronavirus) pandemic. For more information,
Five Local Charities Selected in New Jersey and Washington, D.C. Areas PRINCETON, N.J. – March 30, 2020 – Established in late 2019 by Otsuka America Pharmaceutical, Inc., the Sozosei Foundation has committed $500,000 in donations to five local charities in central New Jersey and Washington, D.C. areas to support those impacted by the Covid-19 Pandemic. The charities selected focus on an